<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2013-5-91-96</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-242</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>СЕРДЦЕ И ВОЗРАСТ (ЧАСТЬ III): МЕТОДЫ ВОЗДЕЙСТВИЯ НА ПРОЦЕССЫ СТАРЕНИЯ</article-title><trans-title-group xml:lang="en"><trans-title>HEART AND AGE (PART III): MODIFYING AGEING PROCESSES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акашева</surname><given-names>Д. У.</given-names></name><name name-style="western" xml:lang="en"><surname>Akasheva</surname><given-names>D. U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м.н., с. н.с. отдела комплексного снижения риска неинфекционных заболеваний</p><p>Тел.: 8–903–526–44–81 </p></bio><bio xml:lang="en"><p>tel.: 8–903–526–44–81</p></bio><email xlink:type="simple">dariga-akasheva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плохова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Plokhova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант отдела</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стражеско</surname><given-names>И. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Strazhesko</surname><given-names>I. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м.н., в. н.с. отдела</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дудинская</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Dudinskaya</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м.н., н. с. отдела</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткачева</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkacheva</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., проф., руководитель отдела</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ “Государственный научно-исследовательский центр профилактической медицины” Минздрава России, Москва</institution></aff><aff xml:lang="en"><institution>State Research Centre for Preventive Medicine, Moscow</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2013</year></pub-date><volume>12</volume><issue>5</issue><fpage>91</fpage><lpage>96</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Акашева Д.У., Плохова Е.В., Стражеско И.Д., Дудинская Е.Н., Ткачева О.Н., 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Акашева Д.У., Плохова Е.В., Стражеско И.Д., Дудинская Е.Н., Ткачева О.Н.</copyright-holder><copyright-holder xml:lang="en">Akasheva D.U., Plokhova E.V., Strazhesko I.D., Dudinskaya E.N., Tkacheva O.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/242">https://cardiovascular.elpub.ru/jour/article/view/242</self-uri><abstract><p>В настоящее время наблюдается рост популяции пожилых людей. Возраст является одним из основных факторов риска (ФР) сердечно-сосудистых заболеваний. Тем не менее, основные усилия специалистов профилактической медицины направлены на “модифицируемые” ФР, такие как артериальная гипертония, гиперхолестеринемия, курение и т. д., в то время как возраст рассматривается как не модифицируемый, не поддающийся коррекции ФР. В связи с чем, представляется важным определение механизмов старения сердца и возможных способов влияния на него. Все известные на сегодня методы воздействия на процессы старения сердца не имеют до сих пор клинического применения и требуют дальнейшего изучения. Основные методы воздействия представлены в данной статье. </p></abstract><trans-abstract xml:lang="en"><p>The share of elderly people in the general population has been steadily increasing. Age is one of the main risk factors (RFs) of cardiovascular disease. However, the current focus of preventive medicine is on modifiable RFs, such as arterial hypertension, hypercholesterolemia, and smoking, while age is regarded as a nonmodifiable, non-correctable RF. This emphasises the importance of the identification of cardiac ageing mechanisms and potential modifying interventions. All the existing methods which target cardiac ageing processes have not been used in the clinical settings and require further research. The key intervention methods are described in the paper. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>старение</kwd><kwd>сердце</kwd><kwd>теломеры</kwd><kwd>митохондрии</kwd><kwd>окислительный стресс</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ageing</kwd><kwd>heart</kwd><kwd>telomeres</kwd><kwd>mitochondria</kwd><kwd>oxidative stress</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">José Marín-García. Aging and the Heart. A Post-Genomic View. Springer 2008; 443–4.</mixed-citation><mixed-citation xml:lang="en">José Marín-García. Aging and the Heart. A Post-Genomic View. Springer 2008; 443–4.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res 2007; 100: 460–73.</mixed-citation><mixed-citation xml:lang="en">Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res 2007; 100: 460–73.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Duque G. Apoptosis in cardiovascular aging research: future directions. Am J Geriatr Cardiol 2000; 9: 263–4.</mixed-citation><mixed-citation xml:lang="en">Duque G. Apoptosis in cardiovascular aging research: future directions. Am J Geriatr Cardiol 2000; 9: 263–4.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Tsujimoto Y, Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 2007; 12 (5): 835–40.</mixed-citation><mixed-citation xml:lang="en">Tsujimoto Y, Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 2007; 12 (5): 835–40.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Atlante A, Seccia TM, Marra E, et al. The rate of ATP export in the extramitochondrial phase via the adenine nucleotide translocator changes in aging in mitochondria isolated from heart left ventricle of either normotensive or spontaneously hypertensive rats. Mech Ageing Dev 2011; 132 (10): 488–95.</mixed-citation><mixed-citation xml:lang="en">Atlante A, Seccia TM, Marra E, et al. The rate of ATP export in the extramitochondrial phase via the adenine nucleotide translocator changes in aging in mitochondria isolated from heart left ventricle of either normotensive or spontaneously hypertensive rats. Mech Ageing Dev 2011; 132 (10): 488–95.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Giorgio V, Soriano ME, Basso E, et al. Cyclophilin D in mitochondrial pathophysiology. Biochim Biophys Acta 2010; 1797 (6–7): 1113–8.</mixed-citation><mixed-citation xml:lang="en">Giorgio V, Soriano ME, Basso E, et al. Cyclophilin D in mitochondrial pathophysiology. Biochim Biophys Acta 2010; 1797 (6–7): 1113–8.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Trifunovic A, Hansson A, Wredenberg A, et al. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci USA 2005; 102: 17993–8.</mixed-citation><mixed-citation xml:lang="en">Trifunovic A, Hansson A, Wredenberg A, et al. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci USA 2005; 102: 17993–8.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Faucher F, Doublié S, Jia Z. 8-oxoguanine DNA glycosylases: one lesion, three subfamilies. Int J Mol Sci 2012; 13 (6): 6711–29.</mixed-citation><mixed-citation xml:lang="en">Faucher F, Doublié S, Jia Z. 8-oxoguanine DNA glycosylases: one lesion, three subfamilies. Int J Mol Sci 2012; 13 (6): 6711–29.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dobson AW, Xu Y, Kelley MR, et al. Enhanced mitochondrial DNA repair and cellular survival after oxidative stress by targeting the human 8-oxoguanine glycosylase repair enzyme to mitochondria. J Biol Chem 2000; 275: 37518–23.</mixed-citation><mixed-citation xml:lang="en">Dobson AW, Xu Y, Kelley MR, et al. Enhanced mitochondrial DNA repair and cellular survival after oxidative stress by targeting the human 8-oxoguanine glycosylase repair enzyme to mitochondria. J Biol Chem 2000; 275: 37518–23.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sato A, Nakada K, Hayashi J. Mitochondrial dynamics and aging: Mitochondrial interaction preventing individuals from expression of respiratory deficiency caused by mutant mtDNA. Biochim Biophys Acta 2006; 1763 (5–6): 473–81.</mixed-citation><mixed-citation xml:lang="en">Sato A, Nakada K, Hayashi J. Mitochondrial dynamics and aging: Mitochondrial interaction preventing individuals from expression of respiratory deficiency caused by mutant mtDNA. Biochim Biophys Acta 2006; 1763 (5–6): 473–81.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Frantz MC, Wipf P. Mitochondria as a target in treatment. Environ Mol Mutagen 2010; 51 (5): 462–75.</mixed-citation><mixed-citation xml:lang="en">Frantz MC, Wipf P. Mitochondria as a target in treatment. Environ Mol Mutagen 2010; 51 (5): 462–75.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Torchilin VP. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 2006; 8: 343–75.</mixed-citation><mixed-citation xml:lang="en">Torchilin VP. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 2006; 8: 343–75.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Melov S. Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann NY Acad Sci 2000; 908: 219–25.</mixed-citation><mixed-citation xml:lang="en">Melov S. Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann NY Acad Sci 2000; 908: 219–25.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tang YL, Qian K, Zhang YC, et al. A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. J Cardiovasc Pharmacol Ther 2005; 10: 251–63.</mixed-citation><mixed-citation xml:lang="en">Tang YL, Qian K, Zhang YC, et al. A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. J Cardiovasc Pharmacol Ther 2005; 10: 251–63.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Linford NJ, Schriner SE, Rabinovitch PS. Oxidative damage and aging: spotlight on mitochondria. Cancer Res. 2006; 66 (5): 2497–9.</mixed-citation><mixed-citation xml:lang="en">Linford NJ, Schriner SE, Rabinovitch PS. Oxidative damage and aging: spotlight on mitochondria. Cancer Res. 2006; 66 (5): 2497–9.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Abunasra HJ, Smolenski RT, Morrison K, et al. Efficacy of adenoviral gene transfer with manganese superoxide dismutase and endothelial nitric oxide synthase in reducing ischemia and reperfusion injury. Eur J Cardiothorac Surg 2001; 20: 153–8.</mixed-citation><mixed-citation xml:lang="en">Abunasra HJ, Smolenski RT, Morrison K, et al. Efficacy of adenoviral gene transfer with manganese superoxide dismutase and endothelial nitric oxide synthase in reducing ischemia and reperfusion injury. Eur J Cardiothorac Surg 2001; 20: 153–8.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Melo LG, Agrawal R, Zhang L, et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of hemeoxygenase gene. Circulation 2002; 105: 602–7.</mixed-citation><mixed-citation xml:lang="en">Melo LG, Agrawal R, Zhang L, et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of hemeoxygenase gene. Circulation 2002; 105: 602–7.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X, Pachori AS, Ward CA, et al. Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J 2006; 20: 207–16.</mixed-citation><mixed-citation xml:lang="en">Liu X, Pachori AS, Ward CA, et al. Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J 2006; 20: 207–16.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Littarru GP, Tiano L, Belardinelli R, et al. Coenzyme Q (10), endothelial function, and cardiovascular disease. Biofactors 2011; 37 (5): 366–73.</mixed-citation><mixed-citation xml:lang="en">Littarru GP, Tiano L, Belardinelli R, et al. Coenzyme Q (10), endothelial function, and cardiovascular disease. Biofactors 2011; 37 (5): 366–73.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lesnefsky EJ, He D, Moghaddas S, et al. Reversal of mitochondrial defects before ischemia protects the aged heart. FASEB J 2006; 20: 1543–5.</mixed-citation><mixed-citation xml:lang="en">Lesnefsky EJ, He D, Moghaddas S, et al. Reversal of mitochondrial defects before ischemia protects the aged heart. FASEB J 2006; 20: 1543–5.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kumaran S, Savitha S, Anusuya Devi M, et al. L-carnitine and DL-alpha-lipoic acid reverse the age-related deficit in glutathione redox state in skeletal muscle and heart tissues. Mech Ageing Dev 2004; 125: 507–12.</mixed-citation><mixed-citation xml:lang="en">Kumaran S, Savitha S, Anusuya Devi M, et al. L-carnitine and DL-alpha-lipoic acid reverse the age-related deficit in glutathione redox state in skeletal muscle and heart tissues. Mech Ageing Dev 2004; 125: 507–12.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Torchilin VP. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 2006; 8: 343–75.</mixed-citation><mixed-citation xml:lang="en">Torchilin VP. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 2006; 8: 343–75.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">SofieBekaert, Tim De Meyer. Telomere Attrition as Ageing Biomarker. Anticancer Research 2005; 25: 3011–22.</mixed-citation><mixed-citation xml:lang="en">SofieBekaert, Tim De Meyer. Telomere Attrition as Ageing Biomarker. Anticancer Research 2005; 25: 3011–22.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Fyhrquist F, Saijonmaa O. Telomere length and cardiovascular aging. Ann Med 2012; 44 (1): S138–42.</mixed-citation><mixed-citation xml:lang="en">Fyhrquist F, Saijonmaa O. Telomere length and cardiovascular aging. Ann Med 2012; 44 (1): S138–42.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Oh H, Taffet GE, Youker KA, et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Pro Natl Acad Sci USA 2001; 98: 10308–13.</mixed-citation><mixed-citation xml:lang="en">Oh H, Taffet GE, Youker KA, et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Pro Natl Acad Sci USA 2001; 98: 10308–13.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Madonna R, De Caterina R, Willerson JT, et al. Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration. Eur Heart J 2011; 32 (10): 1190–6.</mixed-citation><mixed-citation xml:lang="en">Madonna R, De Caterina R, Willerson JT, et al. Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration. Eur Heart J 2011; 32 (10): 1190–6.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Voghel G, Thorin-Trescases N, Farhat N, et al. Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients. Mech Ageing Dev 2008; 129: 261–70.</mixed-citation><mixed-citation xml:lang="en">Voghel G, Thorin-Trescases N, Farhat N, et al. Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients. Mech Ageing Dev 2008; 129: 261–70.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Gleichmann U, Gleichmann US, Gleichmann S. From cardiovascular prevention to anti-aging medicine: influence on telomere and cell aging. Dtsch Med Wochenschr 2011; 136 (38): 1913–6.</mixed-citation><mixed-citation xml:lang="en">Gleichmann U, Gleichmann US, Gleichmann S. From cardiovascular prevention to anti-aging medicine: influence on telomere and cell aging. Dtsch Med Wochenschr 2011; 136 (38): 1913–6.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Werner Ch, Hanhoun M. Effects of Physical Exercise on Myocardial Telomere-Regulating Proteins. JACC 2008; 52: 470–82.</mixed-citation><mixed-citation xml:lang="en">Werner Ch, Hanhoun M. Effects of Physical Exercise on Myocardial Telomere-Regulating Proteins. JACC 2008; 52: 470–82.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt U, del Monte F, Miyamoto MI, et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca (2+) -ATPase. Circulation 2000; 101 (7): 790–6.</mixed-citation><mixed-citation xml:lang="en">Schmidt U, del Monte F, Miyamoto MI, et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca (2+) -ATPase. Circulation 2000; 101 (7): 790–6.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Xin W, Lu XC, Li XY, et al. Effects of sarcoplasmic reticulum Ca (2+) -ATPase gene transfer in a minipig model of chronic ischemic heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39 (4): 336–42.</mixed-citation><mixed-citation xml:lang="en">Xin W, Lu XC, Li XY, et al. Effects of sarcoplasmic reticulum Ca (2+) -ATPase gene transfer in a minipig model of chronic ischemic heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39 (4): 336–42.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt U, Zhu X, Lebeche D, et al. In vivo gene transfer of parvalbumin improves diastolic function in aged rat hearts. Cardiovasc Res 2005; 66 (2): 318–23.</mixed-citation><mixed-citation xml:lang="en">Schmidt U, Zhu X, Lebeche D, et al. In vivo gene transfer of parvalbumin improves diastolic function in aged rat hearts. Cardiovasc Res 2005; 66 (2): 318–23.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Wang W, Martindale J, Metzger JM. Parvalbumin: Targeting calcium handling in cardiac diastolic dysfunction. Gen Physiol Biophys 2009; 28 Spec No Focus: F3–6.</mixed-citation><mixed-citation xml:lang="en">Wang W, Martindale J, Metzger JM. Parvalbumin: Targeting calcium handling in cardiac diastolic dysfunction. Gen Physiol Biophys 2009; 28 Spec No Focus: F3–6.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Terman A, Brunk UT. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 2005; 68 (3): 355–65.</mixed-citation><mixed-citation xml:lang="en">Terman A, Brunk UT. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 2005; 68 (3): 355–65.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Donati A. The involvement of macroautophagy in aging and anti-aging interventions. Mol Aspects Med 2006; 27: 455–70.</mixed-citation><mixed-citation xml:lang="en">Donati A. The involvement of macroautophagy in aging and anti-aging interventions. Mol Aspects Med 2006; 27: 455–70.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Donati A, Cavallini G, Carresi C, et al. Anti-aging effects of anti-lipolytic drugs. Exp Gerontol 2004; 39 (7): 1061–7.</mixed-citation><mixed-citation xml:lang="en">Donati A, Cavallini G, Carresi C, et al. Anti-aging effects of anti-lipolytic drugs. Exp Gerontol 2004; 39 (7): 1061–7.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Nair S, Ren J. Autophagy and cardiovascular aging: Lesson learned from rapamycin. Cell Cycle 2012; 11 (11): 2092–9.</mixed-citation><mixed-citation xml:lang="en">Nair S, Ren J. Autophagy and cardiovascular aging: Lesson learned from rapamycin. Cell Cycle 2012; 11 (11): 2092–9.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Katewa SD, Kapahi P. Role of TOR signaling in aging and related biological processes in Drosophila melanogaster. Exp Gerontol 2011; 46 (5): 382–90.</mixed-citation><mixed-citation xml:lang="en">Katewa SD, Kapahi P. Role of TOR signaling in aging and related biological processes in Drosophila melanogaster. Exp Gerontol 2011; 46 (5): 382–90.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Inuzuka Y, Okuda J, Kawashima T, et al. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation 2009; 120 (17): 1695–703.</mixed-citation><mixed-citation xml:lang="en">Inuzuka Y, Okuda J, Kawashima T, et al. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation 2009; 120 (17): 1695–703.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Blagosklonny MV. Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to. Aging 2012; 4 (5): 350–8.</mixed-citation><mixed-citation xml:lang="en">Blagosklonny MV. Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to. Aging 2012; 4 (5): 350–8.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Blagosklonny MV. An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Discov Today 2007; 12 (5–6): 218–24.</mixed-citation><mixed-citation xml:lang="en">Blagosklonny MV. An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Discov Today 2007; 12 (5–6): 218–24.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Liu M, Liu F. Resveratrol inhibits mTOR signaling by targeting DEPTOR. Commun Integr Biol 2011; 4 (4): 382–4.</mixed-citation><mixed-citation xml:lang="en">Liu M, Liu F. Resveratrol inhibits mTOR signaling by targeting DEPTOR. Commun Integr Biol 2011; 4 (4): 382–4.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Valenzano DR, Terzibasi E, Genade T, et al. Resveratrol prolongs life span and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 2006; 16: 296–300.</mixed-citation><mixed-citation xml:lang="en">Valenzano DR, Terzibasi E, Genade T, et al. Resveratrol prolongs life span and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 2006; 16: 296–300.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 2007; 35 (5): 1156–60.</mixed-citation><mixed-citation xml:lang="en">de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 2007; 35 (5): 1156–60.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Donnelly LE, Newton R, Kennedy GE, et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 2004; 287 (4): L774–83.</mixed-citation><mixed-citation xml:lang="en">Donnelly LE, Newton R, Kennedy GE, et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 2004; 287 (4): L774–83.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">de Grey AD, Alvarez PJ, Brady RO, et al. Medical bioremediation: prospects for the application of microbial catabolic diversity to aging and several major age-related diseases. Ageing Res Rev 2005; 4 (3): 315–38.</mixed-citation><mixed-citation xml:lang="en">de Grey AD, Alvarez PJ, Brady RO, et al. Medical bioremediation: prospects for the application of microbial catabolic diversity to aging and several major age-related diseases. Ageing Res Rev 2005; 4 (3): 315–38.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Dhahbi JM, Tsuchiya T, Kim HJ, et al. Gene expression and physiologic responses of the heart to the initiation and withdrawal of caloric restriction. J Gerontol A Biol Sci Med Sci 2006; 61: 218–31.</mixed-citation><mixed-citation xml:lang="en">Dhahbi JM, Tsuchiya T, Kim HJ, et al. Gene expression and physiologic responses of the heart to the initiation and withdrawal of caloric restriction. J Gerontol A Biol Sci Med Sci 2006; 61: 218–31.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Richie JP, Leutzinger Y, Parthasarathy S, et al. Methionine restriction increases blood glutathione and longevity in F344 rats. FASEB J 1994; 8: 1302–7.</mixed-citation><mixed-citation xml:lang="en">Richie JP, Leutzinger Y, Parthasarathy S, et al. Methionine restriction increases blood glutathione and longevity in F344 rats. FASEB J 1994; 8: 1302–7.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Zainal TA, Oberley TD, Allison DB, et al. Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle. FASEB J 2000; 14: 1825–36.</mixed-citation><mixed-citation xml:lang="en">Zainal TA, Oberley TD, Allison DB, et al. Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle. FASEB J 2000; 14: 1825–36.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Roth GS, Lane MA, Ingram DK, et al. Biomarkers of caloric restriction may predict longevity in humans. Science 2002; 297 (5582): 811.</mixed-citation><mixed-citation xml:lang="en">Roth GS, Lane MA, Ingram DK, et al. Biomarkers of caloric restriction may predict longevity in humans. Science 2002; 297 (5582): 811.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Barja G. Aging in vertebrates, and the effect of caloric restriction: a mitochondrial free radical production-DNA damage mechanism? Biol Rev 2004; 79: 235–51.</mixed-citation><mixed-citation xml:lang="en">Barja G. Aging in vertebrates, and the effect of caloric restriction: a mitochondrial free radical production-DNA damage mechanism? Biol Rev 2004; 79: 235–51.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Nisoli E, Tonello C, Cardile A, et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005; 310: 314–7.</mixed-citation><mixed-citation xml:lang="en">Nisoli E, Tonello C, Cardile A, et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005; 310: 314–7.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Donati A, Taddei M, Cavallini G, et al. Stimulation of macroautophagy can rescue older cells from 8-OHdG mtDNA accumulation: a safe and easy way to meet goals in the SENS agenda. Rejuvenation Res 2006; 9: 408–12.</mixed-citation><mixed-citation xml:lang="en">Donati A, Taddei M, Cavallini G, et al. Stimulation of macroautophagy can rescue older cells from 8-OHdG mtDNA accumulation: a safe and easy way to meet goals in the SENS agenda. Rejuvenation Res 2006; 9: 408–12.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Ingram DK, Zhu M, Mamczarz J, et al. Calorie restriction mimetics: an emerging research field. Aging Cell 2006; 5: 97–108.</mixed-citation><mixed-citation xml:lang="en">Ingram DK, Zhu M, Mamczarz J, et al. Calorie restriction mimetics: an emerging research field. Aging Cell 2006; 5: 97–108.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Bulterijs S. Metformin as a geroprotector. Rejuvenation Res 2011; 14 (5): 469–82.</mixed-citation><mixed-citation xml:lang="en">Bulterijs S. Metformin as a geroprotector. Rejuvenation Res 2011; 14 (5): 469–82.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Corbi G, Conti V, Scapagnini G, et al. Role of sirtuins, calorie restriction and physical activity in aging. Front Biosci (Elite Ed) 2012; 4: 768–78.</mixed-citation><mixed-citation xml:lang="en">Corbi G, Conti V, Scapagnini G, et al. Role of sirtuins, calorie restriction and physical activity in aging. Front Biosci (Elite Ed) 2012; 4: 768–78.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Iemitsu M, Miyauchi T, Maeda S, et al. Exercise training improves cardiac function-related gene levels through thyroid hormone receptor signaling in aged rats. Am J Physiol Heart Circ Physiol 2004; 286: H1696–705.</mixed-citation><mixed-citation xml:lang="en">Iemitsu M, Miyauchi T, Maeda S, et al. Exercise training improves cardiac function-related gene levels through thyroid hormone receptor signaling in aged rats. Am J Physiol Heart Circ Physiol 2004; 286: H1696–705.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Armin Arbab-Zadeh, Erika Dijk, Anand Prasad, et al. Effect of Aging and Physical Activity on Left Ventricular Compliance. Circulation 2004; 110: 1799–805.</mixed-citation><mixed-citation xml:lang="en">Armin Arbab-Zadeh, Erika Dijk, Anand Prasad, et al. Effect of Aging and Physical Activity on Left Ventricular Compliance. Circulation 2004; 110: 1799–805.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Choi SY, Chang HJ, Choi SI, et al. Long-term exercise training attenuates age-related diastolic dysfunction: association of myocardial collagen cross-linking. J Korean Med Sci 2009; 24 (1): 32–9.</mixed-citation><mixed-citation xml:lang="en">Choi SY, Chang HJ, Choi SI, et al. Long-term exercise training attenuates age-related diastolic dysfunction: association of myocardial collagen cross-linking. J Korean Med Sci 2009; 24 (1): 32–9.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Conti V, Corbi G, Russomanno G, et al. Oxidative stress efects on endothelial cells treated with dierent athletes’ sera. Medicine&amp; Science in Sports &amp; Exercise 2013; 44 (1): 39–49.</mixed-citation><mixed-citation xml:lang="en">Conti V, Corbi G, Russomanno G, et al. Oxidative stress efects on endothelial cells treated with dierent athletes’ sera. Medicine&amp; Science in Sports &amp; Exercise 2013; 44 (1): 39–49.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Graziamaria Corbi, Valeria Conti, GiusyRussomanno, et al. Is Physical Activity Able to Modify Oxidative Damage in Cardiovascular Aging? Oxidative Medicine and Cellular Longevity 2012; 2012: 728547.</mixed-citation><mixed-citation xml:lang="en">Graziamaria Corbi, Valeria Conti, GiusyRussomanno, et al. Is Physical Activity Able to Modify Oxidative Damage in Cardiovascular Aging? Oxidative Medicine and Cellular Longevity 2012; 2012: 728547.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Kemi OJ, Ceci M, Condorelli G, et al. Myocardial sarcoplasmic reticulum Ca2+ ATPase function is increased by aerobic interval training. Eur J Cardiovasc Prev Rehabil 2008; 15 (2): 145–8.</mixed-citation><mixed-citation xml:lang="en">Kemi OJ, Ceci M, Condorelli G, et al. Myocardial sarcoplasmic reticulum Ca2+ ATPase function is increased by aerobic interval training. Eur J Cardiovasc Prev Rehabil 2008; 15 (2): 145–8.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Christian Werner, Milad Hanhoun, Thomas Widmann, et al. Effects of Physical Exercise on Myocardial Telomere-Regulating Proteins, Survival Pathways, and Apoptosis. JACC 2008; 52 (6): 470–82.</mixed-citation><mixed-citation xml:lang="en">Christian Werner, Milad Hanhoun, Thomas Widmann, et al. Effects of Physical Exercise on Myocardial Telomere-Regulating Proteins, Survival Pathways, and Apoptosis. JACC 2008; 52 (6): 470–82.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
